HR or Marketing?Claim Your Free Employer Account
Isomerase Therapeutics Claimed Company
Isomerase Therapeutics Company Culture
Isomerase Therapeutics Culture
This score is derived from employee ratings & reviewsTop Rated Culture Dimensions
Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterIsomerase Therapeutics Company Information
| Headquarter | Chesterford Research Park, Newnham Building Little Chesterford, Essex CB10 1TS United Kingdom |
|---|---|
| Website | www.isomerase.com/ |
| Company Status | Private |
Isomerase Therapeutics Employees
1 employee at Isomerase Therapeutics has reviewed Isomerase Therapeutics across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.
Joining Isomerase Therapeutics - Employee Onboarding
The prevailing opinion from Comparably users about their company is that it was very prepared on their first day. Employees concluded that their overall onboarding experience was positive. 73% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
Isomerase Therapeutics KPIs and OKRs
At this moment no Isomerase Therapeutics employees have provided insight into whether or not they clearly understand Isomerase Therapeutics' KPIs and OKRs.
Are your company's goals clear, and are you invested in them?
Are the KPIs/OKRs for your department clear?
Isomerase Therapeutics Careers
Isomerase Therapeutics Jobs
No Recent Jobs found for Isomerase Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
Let Isomerase Therapeutics Know You Want To Work There
Frequently Asked Questions regarding Isomerase Therapeutics
What is Isomerase Therapeutics address?
Isomerase Therapeutics location is at Chesterford Research Park, Newnham Building
What is Isomerase Therapeutics eNPS?
The eNPS for Isomerase Therapeutics is 100
×